These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6854339)

  • 1. Mammalian drug metabolism.
    Nelson SD; Gordon WP
    J Nat Prod; 1983 Jan; 46(1):71-8. PubMed ID: 6854339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
    Gordon WP; Huitric AC; Seth CL; McClanahan RH; Nelson SD
    Drug Metab Dispos; 1987; 15(5):589-94. PubMed ID: 2891472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse.
    Gordon WP; Forte AJ; McMurtry RJ; Gal J; Nelson SD
    Toxicol Appl Pharmacol; 1982 Sep; 65(3):413-24. PubMed ID: 7157374
    [No Abstract]   [Full Text] [Related]  

  • 4. A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil.
    Gordon P; Khojasteh SC
    Drug Metab Rev; 2015 Feb; 47(1):12-20. PubMed ID: 25512112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of drug metabolism--implications for drug interaction].
    Sitkiewicz D
    Pol Merkur Lekarski; 2000 Sep; 9(51):595-7. PubMed ID: 11126981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation of pennyroyal oil hepatotoxicity in the mouse.
    Sztajnkrycer MD; Otten EJ; Bond GR; Lindsell CJ; Goetz RJ
    Acad Emerg Med; 2003 Oct; 10(10):1024-8. PubMed ID: 14525732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation.
    Riches Z; Bloomer J; Patel A; Nolan A; Coughtrie M
    Xenobiotica; 2009 May; 39(5):374-81. PubMed ID: 19280384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide.
    Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD
    Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.
    Bolleddula J; Chowdhury SK
    Drug Metab Rev; 2015; 47(4):534-57. PubMed ID: 26390887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic activation of chemicals to toxic metabolites.
    Guengerich FP; Liebler DC
    Crit Rev Toxicol; 1985; 14(3):259-307. PubMed ID: 3926381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Boldly they rode ... into the mouth of hell". Pennyroyal oil toxicity.
    Mack RB
    N C Med J; 1997; 58(6):456-7. PubMed ID: 9392962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of drugs. I. Basic metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):446-52. PubMed ID: 16161932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes).
    Li AP; Ho MD; Amaral K; Loretz C
    Drug Metab Dispos; 2018 Nov; 46(11):1608-1616. PubMed ID: 29363498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Nezasa K; Tallman MN; Brouwer KL
    Eur J Pharm Sci; 2006 Apr; 27(5):447-86. PubMed ID: 16472997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of (R)-(+)-pulegone in F344 rats.
    Chen LJ; Lebetkin EH; Burka LT
    Drug Metab Dispos; 2001 Dec; 29(12):1567-77. PubMed ID: 11717176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.
    Testa B; Krämer SD
    Chem Biodivers; 2008 Nov; 5(11):2171-336. PubMed ID: 19035562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism and toxicity during hypoxia.
    Jones DP; Aw TY; Shan XQ
    Drug Metab Rev; 1989; 20(2-4):247-60. PubMed ID: 2680383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II enzymes and bioactivation.
    Hinson JA; Forkert PG
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.
    Thomassen D; Slattery JT; Nelson SD
    J Pharmacol Exp Ther; 1990 May; 253(2):567-72. PubMed ID: 2338648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1985; 13(4):398-405. PubMed ID: 2863101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.